Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.

MLA

Egan, Michael F., et al. “Variation in GRM3 Affects Cognition, Prefrontal Glutamate, and Risk for Schizophrenia.” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 34, Aug. 2004, pp. 12604–09. EBSCOhost, https://doi.org/10.1073/pnas.0405077101.

APA

Egan, M. F., Straub, R. E., Goldberg, T. E., Yakub, I., Callicott, J. H., Hariri, A. R., Mattay, V. S., Bertolino, A., Hyde, T. M., Shannon-Weickert, C., Akil, M., Crook, J., Vakkalanka, R. K., Balkissoon, R., Gibbs, R. A., Kleinman, J. E., & Weinberger, D. R. (2004). Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America, 101(34), 12604–12609. https://doi.org/10.1073/pnas.0405077101

Chicago

Egan, Michael F, Richard E Straub, Terry E Goldberg, Imtiaz Yakub, Joseph H Callicott, Ahmad R Hariri, Venkata S Mattay, et al. 2004. “Variation in GRM3 Affects Cognition, Prefrontal Glutamate, and Risk for Schizophrenia.” Proceedings of the National Academy of Sciences of the United States of America 101 (34): 12604–9. doi:10.1073/pnas.0405077101.